Haemorrheological changes in IgA nephropathy
Zsolt Sarszegi, Lajos Kollar, Katalin Torok, Gabor Kassai, Tibor Kovcs, Laszlo Wagner, Kalman Toth, Judit NagyMed Sci Monit 1999; 5(5): CR856-861 :: ID: 503328
Abstract
Amongst factors influencing the progression of IgA nephropathy (NP), the role of pathological haemorrheological parameters has recently aroused increasing interest. We undertook investigations in order to obtain answers whether IgA NP patients demonstrate haemorrheological changes and if so, what is their association with serum IgA and plasma fibrinogen levels, as well as whether there is any association between pathological haemorrheological parameters and clinical findings.Plasma, whole blood viscosity (p<0.001) and red blood cell (RBC) aggregation (p<0.05) were significantly
higher in patients with IgA NP (n=57), in comparison to healthy controls. We noted positive but low-level significant correlations between plasma viscosity and serum IgA (p<0.05), cholesterol (p<0.05) and triglyceride levels (p<0.01). However, we did not reveal any significant correlation between the plasma's viscosity and plasma fibrinogen. Plasma fibrinogen demonstrated a positive significant correlation with the serum creatinine level (p<0.01), proteinuria (p<0.05) and a negative correlation with the endogenous creatinine clearance (p<0.001). We noted a positive low-level correlation between whole blood viscosity and the endogenous creatinine clearance (p<0.05) and a negative one between whole blood viscosity and the serum creatinine level (p<0.05). IgA NP patients with elevated serum IgA levels (³4.2 g/l, n=23) had significantly elevated serum triglyceride levels (p<0.05), plasma viscosity (p<0.001), RBC aggregation (p<0.05) and a significantly lower endogenous creatinine clearance (p<0.05), in comparison to patients with normal serum IgA levels (<4.2 g/l, n=34). We noted no significant differences between haemorrheological parameters of subgroups with elevated (³4.0 g/l, n=30) and those with normal plasma fibrinogen levels (<4.0 g/l, n=27). Patients with elevated plasma fibrinogen levels presented with a significantly higher proteinuria (p<0.05) and a significantly lower endogenous
creatinine clearance, in comparison to patients with normal plasma fibrinogen levels. Thus, an elevated serum IgA level may have an effect on the progression of IgANP, by increasing plasma and whole blood viscosity. The elevated plasma and whole blood viscosity levels cause vasodilatation of the afferent arterioles resulting in hyperfiltration with the progression of nephropathy. High plasma fibrinogen levels result in poor prognosis, independently of its known rheological effect.
Keywords: Fibrinogen, IgA nephropathy, haemorrheology
Editorial
01 April 2025 : Editorial
Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to HumansDOI: 10.12659/MSM.949109
Med Sci Monit 2025; 31:e949109
In Press
Clinical Research
Impact of Voltage Level on Hospitalization and Mortality in Electrical Injury Cases: A Retrospective Analys...Med Sci Monit In Press; DOI: 10.12659/MSM.947675
Clinical Research
Comparative Study of Plantar Load and Foot Posture Characteristics in Male Elite Squash Players and Non-Ath...Med Sci Monit In Press; DOI: 10.12659/MSM.947828
Clinical Research
Dental Students’ Opinions on Use of Artificial Intelligence: A Survey StudyMed Sci Monit In Press; DOI: 10.12659/MSM.947658
Database Analysis
Defining Effect Size Standards in Temporomandibular Joint and Masticatory Muscle ResearchMed Sci Monit In Press; DOI: 10.12659/MSM.948365
Most Viewed Current Articles
17 Jan 2024 : Review article 8,126,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 703,007
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 30,250
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 24,107
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912